Request for Nominations of Candidates To Serve on the Board of Scientific Counselors, Coordinating Office for Terrorism Preparedness and Emergency Response (BSC, COTPER), 18577-18578 [E9-9331]
Download as PDF
<![CDATA[
18577
Federal Register / Vol. 74, No. 77 / Thursday, April 23, 2009 / Notices
Missouri Federal Savings Bank (to be
known as 1st Cameron State Bank), both
of Cameron, Missouri, upon its
conversion to a commerical bank.
Board of Governors of the Federal Reserve
System, April 20, 2009.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. E9–9310 Filed 4–22–09; 8:45 am]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects:
Title: Tribal TANF Data Report, TANF
Annual Report, and Reasonable Cause/
Corrective Action Documentation
Process- Final.
OMB No.: 0970–0215.
Description: 42 U.S.C. 612 (Section
412 of the Social Security Act as
amended by Public Law 104–193, the
Personal Responsibility and Work
Opportunity Reconciliation Act of 1996
(PRWORA)), mandates that Federallyrecognized Indian Tribes with approved
Tribal TANF program collect and
submit to the Secretary of the
Department of Health and Human
Services data on the recipients served
by the Tribe’s programs. This
information includes both aggregated
and disaggregated data on case
characteristics and individual
characteristics. In addition, Tribes that
are subject to a penalty are allowed to
provide reasonable cause justifications
as to why a penalty should not be
imposed or may develop and implement
corrective compliance procedures to
eliminate the source of the penalty.
Finally, there is an annual report, which
requires the Tribes to describe program
characteristics. All of the above
requirements are currently approved by
OMB and the Administration for
Children and Families is simply
proposing to extend them without any
changes.
Respondents: Indian Tribes.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
sroberts on PROD1PC70 with NOTICES
Final Tribal TANF Data Report ........................................................................
Tribal TANF Annual Report .............................................................................
Tribal TANF Reasonable Cause/Corrective ....................................................
Estimated Total Annual Burden
Hours: 118,048.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
VerDate Nov<24>2008
16:59 Apr 22, 2009
Jkt 217001
62
62
62
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Dated: April 20, 2009.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E9–9340 Filed 4–22–09; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Board of
Scientific Counselors, Coordinating
Office for Terrorism Preparedness and
Emergency Response (BSC, COTPER)
CDC is soliciting nominations for
possible membership on the BSC,
COTPER. This board provides advice
and guidance to the Secretary,
Department of Health and Human
Services (HHS), the Director, CDC, and
the Director, COTPER, concerning
strategies and goals for the programs
and research within the divisions;
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
4
1
1
Average
burden
hours
per
response
451
40
60
Total
burden hours
111,848
2,480
3,720
conducts peer-review of scientific
programs; and monitors the overall
strategic direction and focus of the
divisions.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishment of the board’s
objectives. Nominees will be selected by
the Secretary, HHS, or designee, from
authorities knowledgeable in the fields
relevant to the issues addressed by the
offices and divisions within the
coordinating office and related
disciplines, including: Medicine,
epidemiology, laboratory science,
informatics, behavioral science, social
science, engineering, business, and
crisis leadership. Members may be
invited to serve for terms of up to four
years. Consideration is given to
representation from diverse geographic
areas, both genders, ethnic and minority
groups, and the disabled. Nominees
must be U.S. citizens.
The following information must be
submitted for each candidate: Name,
affiliation, address, telephone number,
e-mail address, and current curriculum
vitae. Nominations should be
accompanied by a letter of
recommendation stating the
qualifications of the nominee and must
be postmarked by May 11, 2009 to:
E:\FR\FM\23APN1.SGM
23APN1
18578
Federal Register / Vol. 74, No. 77 / Thursday, April 23, 2009 / Notices
Matthew Jennings, BSC Coordinator,
CDC, Coordinating Office for Terrorism
Preparedness and Emergency Response,
1600 Clifton Road, NE., Mailstop D–44,
Atlanta, Georgia 30333, Telephone (404)
639–7357.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both CDC and
the Agency for Toxic Substances and
Disease Registry.
Dated: April 17, 2009.
Elaine L. Baker,
Director, Management Analysis and Service
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–9331 Filed 4–22–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on PROD1PC70 with NOTICES
Draft National Institutes of Health
Guidelines for Human Stem Cell
Research Notice
SUMMARY: The National Institutes of
Health (NIH) is requesting public
comment on draft guidelines entitled
‘‘National Institutes of Health
Guidelines for Human Stem Cell
Research’’ (Guidelines).
The purpose of these draft Guidelines
is to implement Executive Order 13505,
issued on March 9, 2009, as it pertains
to extramural NIH-funded research, to
establish policy and procedures under
which NIH will fund research in this
area, and to help ensure that NIHfunded research in this area is ethically
responsible, scientifically worthy, and
conducted in accordance with
applicable law. Internal NIH
procedures, consistent with Executive
Order 13505 and these Guidelines, will
govern the conduct of intramural NIH
research involving human stem cells.
These draft Guidelines would allow
funding for research using human
embryonic stem cells that were derived
from embryos created by in vitro
fertilization (IVF) for reproductive
purposes and were no longer needed for
that purpose. Funding will continue to
be allowed for human stem cell research
using adult stem cells and induced
pluripotent stem cells. Specifically,
these Guidelines describe the conditions
and informed consent procedures that
would have been required during the
derivation of human embryonic stem
cells for research using these cells to be
funded by the NIH. NIH funding for
VerDate Nov<24>2008
16:59 Apr 22, 2009
Jkt 217001
research using human embryonic stem
cells derived from other sources,
including somatic cell nuclear transfer,
parthenogenesis, and/or IVF embryos
created for research purposes, is not
allowed under these Guidelines.
NIH funding of the derivation of stem
cells from human embryos is prohibited
by the annual appropriations ban on
funding of human embryo research
(Consolidated Appropriations Act, 2009,
Pub. L. 110–161, 3/11/09), otherwise
known as the Dickey-Wicker
Amendment.
According to these Guidelines, there
are some uses of human embryonic stem
cells and human induced pluripotent
stem cells that, although those cells may
come from allowable sources, are
nevertheless ineligible for NIH funding.
For questions regarding ongoing NIHfunded research involving human
embryonic stem cells, as well as
pending applications and those
submitted prior to the issuance of Final
Guidelines, see the NIH Guide https://
grants.nih.gov/grants/guide/notice-files/
NOT-OD-09-085.html.
DATES: Written comments must be
received by NIH on or before May 26,
2009.
ADDRESSES: The NIH welcomes public
comment on the draft Guidelines set
forth below. Comments may be entered
at: https://nihoerextra.nih.gov/
stem_cells/add.htm. Comments may
also be mailed to: NIH Stem Cell
Guidelines, MSC 7997, 9000 Rockville
Pike, Bethesda, Maryland 20892–7997.
Comments will be made publicly
available, including any personally
identifiable or confidential business
information they contain.
SUPPLEMENTARY INFORMATION: On March
9, 2009, President Barack H. Obama
issued Executive Order 13505:
Removing Barriers to Responsible
Scientific Research Involving Human
Stem Cells. The Executive Order states
that the Secretary of Health and Human
Services, through the Director of NIH,
may support and conduct responsible,
scientifically worthy human stem cell
research, including human embryonic
stem cell research, to the extent
permitted by law.
The purpose of these draft Guidelines
is to implement Executive Order 13505,
issued on March 9, 2009, as it pertains
to extramural NIH-funded research, to
establish policy and procedures under
which NIH will fund research in this
area, and to help ensure that NIHfunded research in this area is ethically
responsible, scientifically worthy, and
conducted in accordance with
applicable law. Internal NIH
procedures, consistent with Executive
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Order 13505 and these Guidelines, will
govern the conduct of intramural NIH
research involving human stem cells.
Long-standing Department of Health
and Human Services regulations for
Protection of Human Subjects, 45 CFR
part 46, establish safeguards for
individuals who are the sources of many
human tissues used in research,
including non-embryonic human adult
stem cells and human induced
pluripotent stem cells. When research
involving human adult stem cells or
induced pluripotent stem cells
constitutes human subject research,
Institutional Review Board review may
be required and informed consent may
need to be obtained per the
requirements detailed in 45 CFR part 46.
Applicants should consult https://
www.hhs.gov/ohrp/humansubjects/
guidance/45cfr46.htm.
As described in these draft
Guidelines, human embryonic stem
cells are cells that are derived from
human embryos, are capable of dividing
without differentiating for a prolonged
period in culture, and are known to
develop into cells and tissues of the
three primary germ layers. Although
human embryonic stem cells are derived
from embryos, such stem cells are not
themselves human embryos.
Studies of human embryonic stem
cells may yield information about the
complex events that occur during
human development. Some of the most
serious medical conditions, such as
cancer and birth defects, are due to
abnormal cell division and
differentiation. A better understanding
of the genetic and molecular controls of
these processes could provide
information about how such diseases
arise and suggest new strategies for
therapy. Human embryonic stem cells
may also be used to test new drugs. For
example, new medications could be
tested for safety on differentiated
somatic cells generated from human
embryonic stem cells.
Perhaps the most important potential
use of human embryonic stem cells is
the generation of cells and tissues that
could be used for cell-based therapies.
Today, donated tissues and organs are
often used to replace ailing or destroyed
tissue, but the need for transplantable
tissues and organs far outweighs the
available supply. Stem cells, directed to
differentiate into specific cell types,
offer the possibility of a renewable
source of replacement cells and tissues
to treat diseases and conditions,
including Parkinson’s disease,
amyotrophic lateral sclerosis, spinal
cord injury, burns, heart disease,
diabetes, and arthritis.
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 74, Number 77 (Thursday, April 23, 2009)]
[Notices]
[Pages 18577-18578]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9331]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the Board of
Scientific Counselors, Coordinating Office for Terrorism Preparedness
and Emergency Response (BSC, COTPER)
CDC is soliciting nominations for possible membership on the BSC,
COTPER. This board provides advice and guidance to the Secretary,
Department of Health and Human Services (HHS), the Director, CDC, and
the Director, COTPER, concerning strategies and goals for the programs
and research within the divisions; conducts peer-review of scientific
programs; and monitors the overall strategic direction and focus of the
divisions.
Nominations are being sought for individuals who have the expertise
and qualifications necessary to contribute to the accomplishment of the
board's objectives. Nominees will be selected by the Secretary, HHS, or
designee, from authorities knowledgeable in the fields relevant to the
issues addressed by the offices and divisions within the coordinating
office and related disciplines, including: Medicine, epidemiology,
laboratory science, informatics, behavioral science, social science,
engineering, business, and crisis leadership. Members may be invited to
serve for terms of up to four years. Consideration is given to
representation from diverse geographic areas, both genders, ethnic and
minority groups, and the disabled. Nominees must be U.S. citizens.
The following information must be submitted for each candidate:
Name, affiliation, address, telephone number, e-mail address, and
current curriculum vitae. Nominations should be accompanied by a letter
of recommendation stating the qualifications of the nominee and must be
postmarked by May 11, 2009 to:
[[Page 18578]]
Matthew Jennings, BSC Coordinator, CDC, Coordinating Office for
Terrorism Preparedness and Emergency Response, 1600 Clifton Road, NE.,
Mailstop D-44, Atlanta, Georgia 30333, Telephone (404) 639-7357.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 17, 2009.
Elaine L. Baker,
Director, Management Analysis and Service Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-9331 Filed 4-22-09; 8:45 am]
BILLING CODE 4163-18-P
